Caredx (NASDAQ: CDNA) — Perfil da empresa, notícias e dados financeiros
CareDx specializes in advanced diagnostics for transplant patients, enhancing post-transplant care through innovative solutions.
Caredx
CareDx (NASDAQ:CDNA) specializes in advanced diagnostics and monitoring solutions for transplant patients. With a focus on enhancing the lives of those who have undergone organ transplantation, CareDx offers a comprehensive suite of testing services aimed at improving long-term health outcomes. The company is driven by a commitment to innovation, continually developing new technologies and methods to ensure the best possible care for transplant recipients. Their projects range from non-invasive blood tests that monitor organ health to digital tools designed for patient and clinician use, all aimed at optimizing post-transplant care. CareDx's primary objective is to lead in the field of transplant diagnostics by providing reliable, cutting-edge solutions that enhance the quality of care for patients worldwide.
Resumo
Operações
Produtos e/ou serviços de Caredx
- AlloMap - A non-invasive blood test aiding in the detection of heart transplant rejection.
- AlloSure - Offers precise measurement of donor-derived cell-free DNA to monitor organ health post-transplant.
- KidneyCare - Comprehensive testing solutions for kidney transplant recipients to ensure graft health.
- HeartCare - Integrates tests for heart transplant patients to detect rejection and manage patient care.
- AlloHeme - A non-invasive test for hematopoietic cell transplant patients to aid in the monitoring of graft health.
- Transplant Management System - A software platform designed to streamline the care management process for transplant patients.
equipe executiva do Caredx
- John Walter Hanna Jr.President, CEO & Director
- Keith S. KennedyCFO & COO
- Jeffrey A. NovackGeneral Counsel & Secretary
- Jessica MengChief Commercial Officer
- Kashif RathoreChief Technology Officer
- Robert N. WoodwardChief Scientific Officer
- Nina D. DekaHead of Investor Relations
- Natasha Moshirian WagnerVice President of Corporate Communications
- Marica GrskovicChief Strategy Officer
- Jing HuangChief Data & Artificial Intelligence Officer
Principais indicadores financeiros
Resultados divulgados pela Caredx, em USD.
- Cap. de mercado
- 3,7 bi
- Receita (TTM)
- 458,1 mi
- P/L
- 34.7
- LPA (diluído, TTM)
- 2.1
- Dividend yield
- —
- Margem de lucro
- 24.2%
| Fim do ano fiscal | Receita | Resultado operacional | Lucro líquido |
|---|---|---|---|
| 379,8 mi | -25,1 mi | -21,4 mi | |
| 333,8 mi | 40,8 mi | 52,5 mi | |
| 280,3 mi | -203,4 mi | -190,3 mi | |
| 321,8 mi | -77,2 mi | -76,6 mi |